SECTORAL ASSET MANAGEMENT INC
Filing Date
Global Rank
#5,000
/ 8,232
▲ 212
Top Industry
Biotechnology
53.4%
3Y Alpha vs SPY
-13.2%
Period ended 2 months ago
Filed May 15, 2026 · 30d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+24.7%
SPY
+76.3%
Annualised alpha
-13.2%
Max drawdown
−30.5%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
77 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
11.6%
+3.3 pts
Top 5
33.8%
+2.3 pts
Top 10
48.7%
+1.8 pts
HHI
375
Diversified+49
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 94.7% | $110,816,443 |
| Unclassified | 5.3% | $6,253,813 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
18 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | +49,347 | 79,150 | $635,574 | |
| KURA | Kura Oncology, Inc. | +17,370 | 71,480 | $581,132 | |
| GILD | Gilead Sciences, Inc. | +9,605 | 27,490 | $3,831,281 | |
| INSM | INSMED Inc | +8,486 | 19,668 | $3,216,111 | |
| BSX | Boston Scientific Corp | +7,154 | 34,780 | $2,182,445 | |
| BNTX | BioNTech SE | +4,946 | 22,164 | $1,969,936 | |
| IMTX | Immatics N.V. | +3,815 | 66,830 | $657,607 | |
| ABT | Abbott Laboratories | +2,080 | 25,578 | $2,626,093 | |
| CYTK | Cytokinetics Inc | +1,407 | 7,300 | $481,143 | |
| UNH | Unitedhealth Group Inc | +1,362 | 14,957 | $4,047,214 | |
| PRVA | Privia Health Group, Inc. | +1,136 | 27,136 | $558,187 | |
| ORIC | Oric Pharmaceuticals, Inc. | +1,020 | 23,500 | $297,745 | |
| ARGX | Argenx SE | +670 | 3,564 | $2,602,611 | |
| ISRG | Intuitive Surgical Inc | +400 | 5,250 | $2,420,197 | |
| PFE | Pfizer Inc | +350 | 27,500 | $772,200 | |
| EW | Edwards Lifesciences Corp | +88 | 17,338 | $1,388,427 | |
| MRK | Merck & Co., Inc. | +80 | 21,480 | $2,583,829 | |
| INSP | Inspire Medical Systems, Inc. | +25 | 7,225 | $372,665 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | −73,200 | 727,587 | $9,502,286 | |
| SI | Shoulder Innovations, Inc. | −62,028 | 430,407 | $6,253,813 | |
| SNDX | Syndax Pharmaceuticals Inc | −29,520 | 31,680 | $740,044 | |
| TECX | Tectonic Therapeutic, Inc. | −23,196 | 19,059 | $589,113 | |
| RAPP | Rapport Therapeutics, Inc. | −13,504 | 25,421 | $795,423 | |
| ROIV | Roivant Sciences Ltd. | −12,847 | 32,500 | $900,250 | |
| RCUS | Arcus Biosciences, Inc. | −11,875 | 45,070 | $973,512 | |
| VERA | Vera Therapeutics, Inc. | −11,285 | 25,573 | $1,028,801 | |
| OMDA | Omada Health, Inc. | −10,880 | 25,620 | $322,043 | |
| COGT | Cogent Biosciences, Inc. | −10,545 | 22,140 | $852,168 | |
| SMMT | Summit Therapeutics Inc. | −10,010 | 69,615 | $1,319,900 | |
| TRVI | Trevi Therapeutics, Inc. | −9,809 | 74,446 | $888,140 | |
| GPCR | Structure Therapeutics Inc. | −9,770 | 14,102 | $679,716 | |
| AVBP | ArriVent BioPharma, Inc. | −8,242 | 30,013 | $692,399 | |
| DXCM | Dexcom Inc | −5,469 | 23,231 | $1,458,906 | |
| ABBV | AbbVie Inc. | −4,600 | 12,200 | $2,653,378 | |
| ALHC | Alignment Healthcare, Inc. | −4,589 | 26,911 | $474,171 | |
| AMGN | Amgen Inc | −3,860 | 9,210 | $3,240,538 | |
| TARS | Tarsus Pharmaceuticals, Inc. | −3,468 | 11,272 | $790,730 | |
| BBIO | BridgeBio Pharma, Inc. | −3,070 | 8,100 | $601,506 | |
| RDNT | RadNet, Inc. | −3,001 | 7,999 | $447,064 | |
| NKTR | Nektar Therapeutics | −2,634 | 10,851 | $780,729 | |
| JNJ | Johnson & Johnson | −2,082 | 18,218 | $4,453,207 | |
| HNGE | Hinge Health, Inc. | −1,962 | 12,244 | $472,128 | |
| BMRN | Biomarin Pharmaceutical Inc | −1,430 | 9,450 | $533,830 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
10 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| IQV | Iqvia Holdings Inc. | 8,307 | $1,416,675 | |
| BMY | Bristol Myers Squibb Co | 21,150 | $1,282,747 | |
| MDT | Medtronic plc | 11,100 | $961,815 | |
| ARDX | Ardelyx, Inc. | 122,394 | $733,140 | |
| AGMB | Agomab Therapeutics NV | 43,500 | $456,315 | |
| ABVX | Abivax S.A. | 2,340 | $260,559 | |
| MEDP | Medpace Holdings, Inc. | 430 | $206,481 | |
| GH | Guardant Health, Inc. | 1,980 | $182,892 | |
| RVMD | Revolution Medicines, Inc. | 1,830 | $177,967 | |
| PALI | Palisade Bio, Inc. | 88,000 | $154,000 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
5 positions
77 positions ·
$117,070,256 total
· as of Mar 31, 2026
Showing 1–50
of 77 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| EVMN |
Evommune, Inc.
Healthcare
|
Held | 589,005 | $13,541,224 | 11.57% | |
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Reduced | 727,587 | $9,502,286 | 8.12% | |
| SI |
Shoulder Innovations, Inc.
|
Reduced | 430,407 | $6,253,813 | 5.34% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 6,354 | $5,844,218 | 4.99% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Reduced | 18,218 | $4,453,207 | 3.80% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Added | 14,957 | $4,047,214 | 3.46% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Added | 27,490 | $3,831,281 | 3.27% | |
| AMGN |
Amgen Inc
Healthcare
|
Reduced | 9,210 | $3,240,538 | 2.77% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 19,668 | $3,216,111 | 2.75% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Reduced | 7,007 | $3,128,905 | 2.67% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Reduced | 12,200 | $2,653,378 | 2.27% | |
| ABT |
Abbott Laboratories
Healthcare
|
Added | 25,578 | $2,626,093 | 2.24% | |
| ARGX |
Argenx SE
Healthcare
|
Added | 3,564 | $2,602,611 | 2.22% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Added | 21,480 | $2,583,829 | 2.21% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Added | 5,250 | $2,420,197 | 2.07% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,919 | $2,255,336 | 1.93% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 34,780 | $2,182,445 | 1.86% | |
| BNTX |
BioNTech SE
Healthcare
|
Added | 22,164 | $1,969,936 | 1.68% | |
| SYK |
Stryker Corp
Healthcare
|
Reduced | 5,874 | $1,930,137 | 1.65% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Reduced | 9,597 | $1,819,591 | 1.55% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Reduced | 3,508 | $1,724,287 | 1.47% | |
| DXCM |
Dexcom Inc
Healthcare
|
Reduced | 23,231 | $1,458,906 | 1.25% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
NEW | 8,307 | $1,416,675 | 1.21% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Added | 17,338 | $1,388,427 | 1.19% | |
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
Reduced | 69,615 | $1,319,900 | 1.13% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
NEW | 21,150 | $1,282,747 | 1.10% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 25,573 | $1,028,801 | 0.88% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Reduced | 1,710 | $1,013,995 | 0.87% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Reduced | 45,070 | $973,512 | 0.83% | |
| MDT |
Medtronic plc
Healthcare
|
NEW | 11,100 | $961,815 | 0.82% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Reduced | 32,500 | $900,250 | 0.77% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Reduced | 74,446 | $888,140 | 0.76% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
Reduced | 31,618 | $856,531 | 0.73% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 22,140 | $852,168 | 0.73% | |
| RAPP |
Rapport Therapeutics, Inc.
Healthcare
|
Reduced | 25,421 | $795,423 | 0.68% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Reduced | 11,272 | $790,730 | 0.68% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Reduced | 10,851 | $780,729 | 0.67% | |
| PFE |
Pfizer Inc
Healthcare
|
Added | 27,500 | $772,200 | 0.66% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,310 | $764,309 | 0.65% | |
| BOLD |
Boundless Bio, Inc.
Healthcare
|
Held | 678,574 | $746,431 | 0.64% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 31,680 | $740,044 | 0.63% | |
| ARDX |
Ardelyx, Inc.
Healthcare
|
NEW | 122,394 | $733,140 | 0.63% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
Reduced | 30,013 | $692,399 | 0.59% | |
| GPCR |
Structure Therapeutics Inc.
Healthcare
|
Reduced | 14,102 | $679,716 | 0.58% | |
| IMTX |
Immatics N.V.
Healthcare
|
Added | 66,830 | $657,607 | 0.56% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Reduced | 2,800 | $640,444 | 0.55% | |
| SPRY |
ARS Pharmaceuticals, Inc.
Healthcare
|
Added | 79,150 | $635,574 | 0.54% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 8,100 | $601,506 | 0.51% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
Reduced | 19,059 | $589,113 | 0.50% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Added | 71,480 | $581,132 | 0.50% |